Skip to main content

Table 1 Demographics and underlying conditions of 31 patients with invasive fungal tracheobronchitis

From: Invasive fungal tracheobronchitis in mechanically ventilated critically ill patients: underlying conditions, diagnosis, and outcomes

Variable No. of patients (%)
Age, years (mean ± SD) 64.7 ± 13.7
Gender, male 24 (77.4)
Current/ex-smoker 15 (48.4)
Underlying disease 30 (96.8)
 DM 18 (58.1)
 Chronic lung disease 12 (38.7)
  COPD/asthma 8 (25.8)
  Old TB 2 (6.5)
  Bronchiectasis 2 (6.5)
 Solid organ cancer 4 (12.9)
 Hematologic disease 4 (12.9)
 Liver cirrhosis 3 (9.7)
Systemic steroids before diagnosis 17 (54.8)
 Duration of steroids before ICU admission, day, median (IQR) 49 (14–90)
 Daily dosage of steroids, mg, median (IQR) 50 (29–71)
Inhaled corticosteroids before diagnosis 3 (9.7)
H1N1 infection before diagnosis 3 (9.7)
  1. SD standard deviation, DM diabetes mellitus, COPD chronic obstructive pulmonary disease, TB tuberculosis, ICU intensive care unit, IQR interquartile range